Templeton Mary B Esq Insider Trades

Insider Trading History

Track insider trading activity for Templeton Mary B Esq. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $16.3 1,134 shares
Last Trade
May 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.5M 2,206 shares
$21,060.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $576 40,000 shares
Last Trade
Mar 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39B 40,000 shares
$34,830.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $6.08k 421,906 shares
Last Trade
Dec 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.4B 421,906 shares
$34,182.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $720 50,000 shares
Last Trade
Mar 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.96B 50,000 shares
$199,260.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $144 10,000 shares
Last Trade
Jul 28, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.87B 10,000 shares
$286,740.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $133 9,270 shares
Last Trade
Jun 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365M 1,166 shares
$312,660.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $117 8,104 shares
Last Trade
Mar 31, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364M 1,347 shares
$270,540.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $154 10,714 shares
Last Trade
Feb 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.17B 10,714 shares
$388,800.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $97.3 6,758 shares
Last Trade
Dec 31, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28B 2,630 shares
$485,319.24
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $59.4 4,128 shares
Last Trade
Sep 30, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$547M 804 shares
$680,672.16
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $384 26,667 shares
Last Trade
Jul 22, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.9B 33,334 shares
$1,227,478.80
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $670 46,530 shares
Last Trade
Jun 30, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.66B 4,964 shares
$1,542,856.89
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $599 41,566 shares
Last Trade
Mar 31, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.66B 2,836 shares
$2,699,999.58
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel & Corp Sec
Holding Value $912 63,306 shares
Last Trade
Mar 27, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199B 75,000 shares
$2,654,621.43
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Svp, Gen Counsel, & Corp Sec
Holding Value $240 16,666 shares
Last Trade
Mar 06, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146B 25,000 shares
$5,853,780.57
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Senior Vp, General Counsel
Holding Value $691 47,987 shares
Last Trade
Mar 26, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$428B 80,000 shares
$5,354,620.98
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Senior Vp, General Counsel
Holding Value $678 47,115 shares
Last Trade
May 04, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$338B 55,000 shares
$6,148,738.50
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Senior Vp, General Counsel
Holding Value $201 13,925 shares
Last Trade
Mar 31, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36B 1,539 shares
$6,080,671.29
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Senior Vp, General Counsel
Holding Value $1.44k 100,000 shares
Last Trade
Oct 07, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$415B 100,000 shares
$4,152,100.17
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Senior Vp, General Counsel
Holding Value $143 9,931 shares
Last Trade
Sep 30, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36B 2,105 shares
$4,447,058.10
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up